Logo image of SHAK

SHAKE SHACK INC - CLASS A (SHAK) Stock Fundamental Analysis

NYSE:SHAK - New York Stock Exchange, Inc. - US8190471016 - Common Stock - Currency: USD

125.21  -2 (-1.57%)

After market: 124.5 -0.71 (-0.57%)

Fundamental Rating

4

Overall SHAK gets a fundamental rating of 4 out of 10. We evaluated SHAK against 134 industry peers in the Hotels, Restaurants & Leisure industry. SHAK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SHAK shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SHAK was profitable.
SHAK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SHAK reported negative net income in multiple years.
Each year in the past 5 years SHAK had a positive operating cash flow.
SHAK Yearly Net Income VS EBIT VS OCF VS FCFSHAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With a Return On Assets value of 0.72%, SHAK is not doing good in the industry: 61.19% of the companies in the same industry are doing better.
SHAK has a Return On Equity of 2.62%. This is comparable to the rest of the industry: SHAK outperforms 56.72% of its industry peers.
The Return On Invested Capital of SHAK (1.96%) is worse than 72.39% of its industry peers.
Industry RankSector Rank
ROA 0.72%
ROE 2.62%
ROIC 1.96%
ROA(3y)0.08%
ROA(5y)-0.81%
ROE(3y)0.21%
ROE(5y)-2.37%
ROIC(3y)N/A
ROIC(5y)N/A
SHAK Yearly ROA, ROE, ROICSHAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

The Profit Margin of SHAK (0.97%) is worse than 60.45% of its industry peers.
SHAK's Profit Margin has declined in the last couple of years.
SHAK's Operating Margin of 3.10% is on the low side compared to the rest of the industry. SHAK is outperformed by 70.90% of its industry peers.
SHAK's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 46.38%, SHAK is in line with its industry, outperforming 47.01% of the companies in the same industry.
SHAK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.1%
PM (TTM) 0.97%
GM 46.38%
OM growth 3YN/A
OM growth 5Y-7.31%
PM growth 3YN/A
PM growth 5Y-24.54%
GM growth 3Y3.42%
GM growth 5Y0.55%
SHAK Yearly Profit, Operating, Gross MarginsSHAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SHAK is destroying value.
The number of shares outstanding for SHAK has been increased compared to 1 year ago.
The number of shares outstanding for SHAK has been increased compared to 5 years ago.
SHAK has a better debt/assets ratio than last year.
SHAK Yearly Shares OutstandingSHAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SHAK Yearly Total Debt VS Total AssetsSHAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.52 indicates that SHAK is not in any danger for bankruptcy at the moment.
SHAK has a Altman-Z score of 3.52. This is in the better half of the industry: SHAK outperforms 79.10% of its industry peers.
SHAK has a debt to FCF ratio of 6.58. This is a slightly negative value and a sign of low solvency as SHAK would need 6.58 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.58, SHAK is in the better half of the industry, outperforming 74.63% of the companies in the same industry.
SHAK has a Debt/Equity ratio of 0.54. This is a neutral value indicating SHAK is somewhat dependend on debt financing.
SHAK's Debt to Equity ratio of 0.54 is fine compared to the rest of the industry. SHAK outperforms 70.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 6.58
Altman-Z 3.52
ROIC/WACC0.23
WACC8.69%
SHAK Yearly LT Debt VS Equity VS FCFSHAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SHAK has a Current Ratio of 1.91. This is a normal value and indicates that SHAK is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SHAK (1.91) is better than 80.60% of its industry peers.
A Quick Ratio of 1.88 indicates that SHAK should not have too much problems paying its short term obligations.
SHAK's Quick ratio of 1.88 is amongst the best of the industry. SHAK outperforms 82.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.88
SHAK Yearly Current Assets VS Current LiabilitesSHAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

SHAK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.00%, which is quite impressive.
Measured over the past 5 years, SHAK shows a small growth in Earnings Per Share. The EPS has been growing by 4.80% on average per year.
The Revenue has grown by 14.07% in the past year. This is quite good.
SHAK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.07% yearly.
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5Y4.8%
EPS Q2Q%7.69%
Revenue 1Y (TTM)14.07%
Revenue growth 3Y19.18%
Revenue growth 5Y16.07%
Sales Q2Q%10.46%

3.2 Future

SHAK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.66% yearly.
SHAK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.19% yearly.
EPS Next Y47.13%
EPS Next 2Y36.14%
EPS Next 3Y32.1%
EPS Next 5Y29.66%
Revenue Next Year15.18%
Revenue Next 2Y14.04%
Revenue Next 3Y14.03%
Revenue Next 5Y14.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SHAK Yearly Revenue VS EstimatesSHAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
SHAK Yearly EPS VS EstimatesSHAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 136.10, the valuation of SHAK can be described as expensive.
64.18% of the companies in the same industry are cheaper than SHAK, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.32. SHAK is valued rather expensively when compared to this.
SHAK is valuated quite expensively with a Price/Forward Earnings ratio of 74.23.
SHAK's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SHAK is more expensive than 66.42% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SHAK to the average of the S&P500 Index (22.19), we can say SHAK is valued expensively.
Industry RankSector Rank
PE 136.1
Fwd PE 74.23
SHAK Price Earnings VS Forward Price EarningsSHAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SHAK is valued a bit more expensive than the industry average as 75.37% of the companies are valued more cheaply.
SHAK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 133.85
EV/EBITDA 36.93
SHAK Per share dataSHAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHAK does not grow enough to justify the current Price/Earnings ratio.
SHAK's earnings are expected to grow with 32.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.89
PEG (5Y)28.38
EPS Next 2Y36.14%
EPS Next 3Y32.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SHAK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHAKE SHACK INC - CLASS A

NYSE:SHAK (6/17/2025, 8:17:27 PM)

After market: 124.5 -0.71 (-0.57%)

125.21

-2 (-1.57%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners104.91%
Inst Owner Change4.14%
Ins Owners4.39%
Ins Owner Change1.74%
Market Cap5.34B
Analysts76
Price Target116.91 (-6.63%)
Short Float %13.71%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.44%
Min EPS beat(2)-16.46%
Max EPS beat(2)3.58%
EPS beat(4)2
Avg EPS beat(4)2.81%
Min EPS beat(4)-16.46%
Max EPS beat(4)25.4%
EPS beat(8)6
Avg EPS beat(8)46.76%
EPS beat(12)10
Avg EPS beat(12)51.25%
EPS beat(16)14
Avg EPS beat(16)53.19%
Revenue beat(2)0
Avg Revenue beat(2)-2.99%
Min Revenue beat(2)-4.11%
Max Revenue beat(2)-1.86%
Revenue beat(4)0
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-4.11%
Max Revenue beat(4)-1.25%
Revenue beat(8)1
Avg Revenue beat(8)-1.93%
Revenue beat(12)2
Avg Revenue beat(12)-1.86%
Revenue beat(16)3
Avg Revenue beat(16)-1.67%
PT rev (1m)4.46%
PT rev (3m)-16.89%
EPS NQ rev (1m)1.61%
EPS NQ rev (3m)5.31%
EPS NY rev (1m)0%
EPS NY rev (3m)7.61%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-1.72%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE 136.1
Fwd PE 74.23
P/S 4.16
P/FCF 133.85
P/OCF 31.11
P/B 11.29
P/tB 11.29
EV/EBITDA 36.93
EPS(TTM)0.92
EY0.73%
EPS(NY)1.69
Fwd EY1.35%
FCF(TTM)0.94
FCFY0.75%
OCF(TTM)4.02
OCFY3.21%
SpS30.07
BVpS11.09
TBVpS11.09
PEG (NY)2.89
PEG (5Y)28.38
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 2.62%
ROCE 2.59%
ROIC 1.96%
ROICexc 2.47%
ROICexgc 2.47%
OM 3.1%
PM (TTM) 0.97%
GM 46.38%
FCFM 3.11%
ROA(3y)0.08%
ROA(5y)-0.81%
ROE(3y)0.21%
ROE(5y)-2.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.73%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.73%
OM growth 3YN/A
OM growth 5Y-7.31%
PM growth 3YN/A
PM growth 5Y-24.54%
GM growth 3Y3.42%
GM growth 5Y0.55%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 6.58
Debt/EBITDA 1.8
Cap/Depr 127.25%
Cap/Sales 10.27%
Interest Coverage 55.28
Cash Conversion 119.81%
Profit Quality 321.58%
Current Ratio 1.91
Quick Ratio 1.88
Altman-Z 3.52
F-Score6
WACC8.69%
ROIC/WACC0.23
Cap/Depr(3y)162.75%
Cap/Depr(5y)160.36%
Cap/Sales(3y)13.36%
Cap/Sales(5y)13.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5Y4.8%
EPS Q2Q%7.69%
EPS Next Y47.13%
EPS Next 2Y36.14%
EPS Next 3Y32.1%
EPS Next 5Y29.66%
Revenue 1Y (TTM)14.07%
Revenue growth 3Y19.18%
Revenue growth 5Y16.07%
Sales Q2Q%10.46%
Revenue Next Year15.18%
Revenue Next 2Y14.04%
Revenue Next 3Y14.03%
Revenue Next 5Y14.19%
EBIT growth 1Y231.93%
EBIT growth 3YN/A
EBIT growth 5Y7.58%
EBIT Next Year550.21%
EBIT Next 3Y107.28%
EBIT Next 5Y64.57%
FCF growth 1Y166.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.83%
OCF growth 3Y43.11%
OCF growth 5Y13.75%